CtDNA After Chemotherapy in Elderly Patients With Acute Leukemia
ConditionAcute Leukemia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age60-100
SponsorNavy General Hospital, Beijing
About this trial
This study will monitor CtDNA After Chemotherapy in Elderly Patients With AL
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Written informed consent
Male
not pregnant female
patients >=60 years old
Disqualifiers
Pregnancy
HIV positive
patients >=100 years old
Trial population
The population include old AML patients with somatic mutations
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
cumulative incidence of relapse(CIR)
cumulative incidence of relapse
Time frame
through study completion, an average of 1 yearSecondary outcomes
1
overall survival (OS)
overall survival
Time frame
through study completion, an average of 2 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov